The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 3,307,044 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | |||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 2,787,787 | 2,844,681 | SH | SOLE | 2,844,681 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 29,890 | 200 | SH | SOLE | 200 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 16,886,142 | 287,277 | SH | SOLE | 287,277 | 0 | 0 | |||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 1,765,960 | 259,700 | SH | SOLE | 259,700 | 0 | 0 | |||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | 9,922,212 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 6,474,202 | 118,380 | SH | SOLE | 118,380 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 18,924,895 | 612,060 | SH | SOLE | 612,060 | 0 | 0 | |||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 4,069,306 | 103,703 | SH | SOLE | 103,703 | 0 | 0 | |||
DANAHER CORPORATION | COM | 235851102 | 27,144,564 | 108,700 | SH | SOLE | 108,700 | 0 | 0 | |||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 3,229,610 | 195,497 | SH | SOLE | 195,497 | 0 | 0 | |||
DENALI THERAPEUTICS INC | COM | 24823R105 | 4,301,259 | 209,613 | SH | SOLE | 209,613 | 0 | 0 | |||
ELI LILLY & CO | COM | 532457108 | 7,157,232 | 9,200 | SH | SOLE | 9,200 | 0 | 0 | |||
ENGENE HOLDINGS INC | COM | 29286M105 | 2,038,899 | 120,289 | SH | SOLE | 120,289 | 0 | 0 | |||
GERON CORP | COM | 374163103 | 5,053,620 | 1,531,400 | SH | SOLE | 1,531,400 | 0 | 0 | |||
ICON PLC | SHS | G4705A100 | 4,972,060 | 14,800 | SH | SOLE | 14,800 | 0 | 0 | |||
IMMUNOME INC | COM | 45257U108 | 6,473,169 | 262,284 | SH | SOLE | 262,284 | 0 | 0 | |||
JANUX THERAPEUTICS INC | COM | 47103J105 | 7,277,745 | 193,300 | SH | SOLE | 193,300 | 0 | 0 | |||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 7,900,701 | 400,441 | SH | SOLE | 400,441 | 0 | 0 | |||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 36,611,738 | 652,732 | SH | SOLE | 652,732 | 0 | 0 | |||
MERUS N V | COM | N5749R100 | 4,945,960 | 109,837 | SH | SOLE | 109,837 | 0 | 0 | |||
METAGENOMI INC | COM | 59102M104 | 1,406,663 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 4,793,234 | 454,766 | SH | SOLE | 454,766 | 0 | 0 | |||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 6,341,603 | 128,842 | SH | SOLE | 128,842 | 0 | 0 | |||
STEVANATO GROUP S P A | ORD SHS | T9224W109 | 17,655,000 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 8,793,415 | 205,166 | SH | SOLE | 205,166 | 0 | 0 | |||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 10,694,264 | 18,400 | SH | SOLE | 18,400 | 0 | 0 | |||
TOURMALINE BIO INC | COM | 89157D105 | 1,085,460 | 47,400 | SH | SOLE | 47,400 | 0 | 0 | |||
ZYMEWORKS INC | COM | 98985Y108 | 1,531,512 | 145,581 | SH | SOLE | 145,581 | 0 | 0 | |||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 12,499 | 384,573 | SH | SOLE | 384,573 | 0 | 0 |